This Article Full Text Full Text (PDF) All Versions of this Article: 35/10/2331    most recent 01.STR.0000141161.63181.f1v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zweifler, R. M. Articles by Parnell, M. Search for Related Content PubMed PubMed Citation Articles by Zweifler, R. M. Articles by Parnell, M. Related Collections Other Stroke Treatment - Medical Emergency treatment of Stroke

(Stroke. 2004;35:2331.)
© 2004 American Heart Association, Inc.

Original Contributions

Magnesium Sulfate Increases the Rate of Hypothermia Via Surface Cooling and Improves Comfort

From the University of South Alabama Stroke Center (R.M.Z., M.A.M., M.P.), Mobile, Ala; and Medivance, Inc. (M.E.V.), Louisville, Colo.

Correspondence to Dr Richard M. Zweifler, USA Stroke Center, 2451 Fillingim St, Mobile, AL 36617. E-mail rzweifle{at}usouthal.edu

Background and Purpose— Therapeutic hypothermia shows promise as a treatment for acute stroke. Surface cooling techniques are being developed but, although noninvasive, they typically achieve slower cooling rates than endovascular methods. We assessed the hypothesis that the addition of intravenous MgSO₄ to an antishivering pharmacological regimen increases the cooling rate when using a surface cooling technique.

Methods— Twenty-two healthy volunteers were studied. Hypothermia was induced using a surface technique with a target tympanic temperature (Ttym) of 34.5°C (target range 34 to 35°C). Subjects received 1 of the following pharmacological regimens: (1) meperidine monotherapy (n=5); (2) meperidine plus buspirone, 30 to 60 mg PO administered at the time of initiation of cooling (n=4); (3) meperidine and ondansetron, 8 to 16 mg IV administered as an 8 mg bolus at the time of initiation of cooling with an optional second dose after 4 hours as needed for nausea (n=5); or (4) meperidine, ondansetron, and MgSO₄, 4 to 6 g IV bolus followed by 1 to 3 g per hour infusion (n=8). Thermal comfort was evaluated with a 100-mm-long visual analog scale.

Results— More subjects who received MgSO₄ were vasodilated during hypothermia induction (7 of 8 [88%] versus 4 of 14 [29%]; P=0.024). MgSO₄ (coefficient –17.265; P=0.039), weight (1.838, 0.001), and the initial 2-hour meperidine dose (0.726, 0.003) were found to significantly impact the time to achieve Ttym of 35°C. Subjects who received MgSO₄ had significantly higher mean comfort scores than those who did not (48±15 versus 38±12; P<0.001).

Conclusions— Administration of intravenous MgSO₄ increases the cooling rate and comfort when using a surface cooling technique.

Key Words: hypothermia • magnesium sulfate • neuroprotection • stroke

This article has been cited by other articles:

				A. Wadhwa, P. Sengupta, J. Durrani, O. Akca, R. Lenhardt, D. I. Sessler, and A. G. Doufas Magnesium sulphate only slightly reduces the shivering threshold in humans Br. J. Anaesth., June 1, 2005; 94(6): 756 - 762. [Abstract] [Full Text] [PDF]